Richardl Simmons News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This study will be the Second Clinical Trial Evaluating RenovoGem™, a Combination Drug-Device Product, in a Difficult-to-Access Solid Tumor Cancer .

United statesHassan hatoumRichardl simmonsPaula novelliDavid gellerUniversity of pittsburgh school medicineUniversity of pittsburgh medical centerInterventional radiology researchExchange commissionCompany nasdaqNasdaq stock marketOklahoma university ou healthLiver cancer centerCougar national principal investigatorRenovorx incSecurities exchange